Dr. David E. Anderson, VBI’s Senior Vice President of Research, will present this week at the Biotech in Europe Investor Forum. The two-day event will begin tomorrow, September 30th, in Basel, Switzerland.
Dr. Anderson will participate in a vaccines panel discussion co-chaired by Chris Britten, Head of Business Development at Sanofi Pasteur, and Dr. Florian Schödel, the founder of Philimmune, a consulting firm specializing in biologics and vaccines. Dr. Schödel also serves as a member of VBI’s Scientific Advisory Board.
The vaccines panel discussion will begin at 9:45AM Central European Time (UTC +01:00) on September 30th. Following the panel discussion, Dr. Anderson will deliver a presentation for investors at 4:20PM Central European Time (UTC +01:00) in Room Lima.
The Biotech in Europe Forum brings together leading late-stage private and public companies with investors, analysts, money managers, and pharma licensing executives. For more information, visit: http://www.sachsforum.com/basel14/index.html